指南与共识妇科

宾夕法尼亚州医疗补助计划中宫颈癌筛查指南变更前后的依从性

Cervical Cancer Screening Guideline Adherence Before and After Guideline Changes in Pennsylvania Medicaid.
指南 / 共识 · Obstet Gynecol · 2017-01-01

该观察性队列研究分析2007至2013年宾夕法尼亚州医疗补助计划理赔数据,评估2009年美国妇产科医师学会指南变更前后18至64岁持续参保女性的宫颈癌筛查依从性。结果显示指南变更后适当筛查率显著下降,过度筛查显著增加,筛查不足仅在30岁及以上女性中显著增加。

要点

  • 指南变更后适当筛查率在30岁以下女性从45%降至11%,30岁及以上从27%降至6%。
  • 过度筛查在30岁以下女性从6%升至67%,30岁及以上从54%升至65%。
  • 筛查不足仅在30岁及以上女性中显著增加,从20%升至29%。

核心结论

  • 指南变更后观察到宫颈癌过度筛查和筛查不足率高,适当筛查率低。
  • 干预措施应同时针对筛查不足和过度筛查这两个独立但重要的问题。

研究设计与样本

  • 观察性队列研究,使用2007至2013年宾夕法尼亚州医疗补助计划理赔数据。
  • 纳入18至64岁持续参保女性,共29,650名,其中30岁以下17,360名,30岁及以上12,290名。
  • 评估2009年美国妇产科医师学会指南变更前后的指南依从性。
  • 根据Pap测试间隔与指南推荐间隔(±6个月)的比较,分类为筛查不足、适当筛查或过度筛查。
  • 按年龄分层,并通过逻辑回归评估筛查不足和过度筛查的预测因素。

主要发现

  • 适当筛查率在30岁以下女性中从45%(95%CI 44-46%)降至11%(95%CI 11-12%),在30岁及以上女性中从27%(95%CI 26-28%)降至6%(95%CI 6-7%)。
  • 过度筛查率在30岁以下女性中从6%(95%CI 5-6%)升至67%(95%CI 66-68%),在30岁及以上女性中从54%(95%CI 52-55%)升至65%(95%CI 64-67%)。
  • 筛查不足率仅在30岁及以上女性中显著增加,从20%(95%CI 19-21%)升至29%(95%CI 27-30%)。
  • 与筛查不足相关的因素包括:指南变更后的Pap测试、妊娠、管理式医疗参保(30岁以下女性)、黑人种族(30岁以下女性)。
  • 与过度筛查相关的因素包括:指南变更后的Pap测试、更多就诊次数、更多性传播感染检测、白人种族(30岁及以上女性)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess changes in cervical cancer screening after the 2009 American College of Obstetricians and Gynecologists' guideline change and to determine predictors associated with underscreening and overscreening among Medicaid-enrolled women. METHODS: We performed an observational cohort study of Pennsylvania Medicaid claims from 2007 to 2013. We evaluated guideline adherence of 18- to 64-year-old continuously enrolled women before and after the 2009 guideline change. To define adherence, we categorized intervals between Pap tests as longer than (underscreening), within (appropriate screening), or shorter than (overscreening) guideline-recommended intervals (±6-month). We stratified results by age and assessed predictors of underscreening and overscreening through logistic regression. RESULTS: Among 29,650 women, appropriate cervical cancer screening significantly decreased after the guideline change (from 45% [95% confidence interval (CI) 44-46%] to 11% [95% CI 11-12%] among 17,360 younger than 30 year olds and from 27% [95% CI 26-28%] to 6% [95% CI 6-7%] among 12,290 women 30 years old or older). Overscreening significantly increased (from 6% [95% CI 5-6%] to 67% [95% CI 66-68%] in those younger than 30 years old and from 54% [95% CI 52-55%] to 65% [95% CI 64-67%] in those 30 years old or older), whereas underscreening significantly increased only in those 30 years old or older (from 20% [95% CI 19-21%] to 29% [95% CI 27-30%]). Pap tests after guideline change, pregnancy, Managed Care enrollment (in those younger than 30 years old), and black race (in those younger than 30 years old) were associated with underscreening. Pap tests after guideline change, more visits, more sexually transmitted infection testing, and white race (in those 30 years old or older) were associated with overscreening. CONCLUSION: We observed high rates of cervical cancer overscreening and underscreening and low rates of appropriate screening after the guideline change. Interventions should target both underscreening and overscreening to address these separate yet significant issues.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Parekh N, Donohue JM, Men A, et al. Cervical Cancer Screening Guideline Adherence Before and After Guideline Changes in Pennsylvania Medicaid. Obstet Gynecol. 2017. PMID: 27926644. doi:10.1097/AOG.0000000000001804

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。